Completed NA INTERVENTIONAL 1-arm NCT00000955

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Interventions Tuberculin Purified Protein Derivative

Updated 7 times since 2017 Last updated: Sep 28, 2013 Primary completion: Dec 31, 1992 Completion: Dec 31, 1992

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on HIV Infections and Tuberculosis, this trial is completed. The trial is conducted by National Institute of Allergy and Infectious Diseases (NIAID) and has accumulated 7 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)
Warner Lambert - Parke Davis

Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Brooklyn, United States , Chicago, United States , Detroit, United States , New Haven, United States , New Orleans, United States , New York, United States , Newark, United States , Portland, United States , Richmond, United States , The Bronx, United States and 2 more locations